Stop Losing Randomizations to Avoidable Screen Failures
ARIA analyzes every medical record against your study criteria in seconds — so your Sub-I validates, not starts from scratch. More precision. Less waste. More revenue.
Why your clinic is leaving revenue on the table
These aren't opinions — they're the daily reality of every independent clinical trial site.
Screen failures eating your margin
Sponsors cover only a 3:1 ratio. Every failure beyond that comes out of your pocket — in coordinator time, visit costs, and delayed timelines.
Sub-I time wasted on repetitive review
20 to 60 minutes per record. Manually. One criterion at a time. Inconsistent results depending on fatigue and time of day.
Coordinator overload
Manual transcription of clinical data to source documents — hours of non-billable work every single week that your team could spend elsewhere.
From medical record to clinical decision — in seconds
Three steps. Zero manual transcription. Human always in control.
Medical record uploaded. ARIA reads — instantly.
The patient's medical record is uploaded to the system. ARIA reads it immediately and checks every inclusion and exclusion criterion — all simultaneously, in seconds.
Verdict delivered. Data extracted. Ready to use.
ARIA delivers a structured result to your Sub-I — verdict, full analysis, red flags, and all clinical data already organized. No digging. No transcription.
Human has the final word. Always.
Your Sub-I reviews and approves or rejects. Final decision is always human — ARIA documents the full audit trail for FDA compliance and legal accountability.
Three possible outcomes. Always clear. Always structured.
Every analysis delivers one of three verdicts — with full reasoning, red flags, and extracted clinical data attached.
What ARIA extracts from every record
ARIA doesn't just deliver a verdict. It delivers all the structured clinical data your coordinator needs — already extracted, organized, and ready to use. No manual transcription.
With ARIA vs. Without ARIA
The difference isn't just efficiency. It's revenue, team capacity, and operational resilience.
Based on published industry data. All figures are illustrative projections. Individual results vary by therapeutic area, protocol complexity, and site operations.
ARIA doesn't replace your Sub-I. It makes them a Super Sub-I.
The goal was never automation for its own sake. It was giving your best people their time back.
From chart reviewer to clinical decision-maker
When ARIA handles the systematic first pass, your Sub-I stops being a records processor and becomes what they were trained to be: a physician making informed clinical decisions with complete, organized information already in front of them.
- ARIA reviews records while your Sub-I is with patients
- On vacation? ARIA keeps the pipeline moving — no backlog on return
- Saturday night submission? Result ready before Monday morning
- All 40+ criteria checked — never rushed, never fatigued at criterion #38
- Protocol knowledge stays in the system — not tied to any one person
Built from the inside
ARIA wasn't designed in a boardroom. It was built by someone who saw the problem firsthand.
I'm not a physician. I'm not a researcher. I do data entry at a clinical trial site — and honestly, my job is to enter the data correctly and go home.
But I've watched the owners of this clinic — people who spent over 10 years building something real — stress over months when randomizations are low. When the studies slow down, the salaries don't. The rent doesn't. The pressure doesn't.
I saw their pain up close. And I knew AI could help. So I built ARIA for them. Not in a lab. Not in a boardroom.
ARIA was born inside a clinical trial clinic — built by someone who watched the problem happen in real time, and decided to do something about it.
"Time is money."
— BENJAMIN FRANKLIN, 1748
In clinical trials, that time has a very specific price tag. Calculate yours below — free, private, and backed by published research.
What is your clinic leaving on the table every month?
Enter your numbers. See the real cost of manual chart review. No submission required to see your results.
Your Monthly Screen Failure Cost Estimator
Based on peer-reviewed research · NIH/PMC · AutoCruitment · Applied Clinical Trials · Your data stays private.
The Research Behind These Numbers
These projections are grounded in peer-reviewed studies published by the National Institutes of Health — not invented estimates.
- 40% of clinical trial sites report incorrectly excluding eligible patients due to eligibility criteria misinterpretation.
- Pre-screening at most sites is informal, unstandardized, and undocumented — systematically excluding patients who would qualify if formally evaluated.
- Systematic review of medical records identifies up to 3x more eligible patients compared to informal manual review.
ARIA applies the same systematic rigor to every patient record — eliminating the human variability that costs sites revenue they never see.
Individual results vary by site, therapeutic area, and protocol complexity. These projections are illustrative only and do not constitute a guarantee of results.
Not for everyone — and that's the point
ARIA is built for independent clinical trial sites.
If you're a hospital system, a pharmaceutical company, or a CRO managing hundreds of sites — there are enterprise platforms built for your scale. If you're a Site Director running your own clinic, managing real studies with a real team, and absorbing the real cost of every screen failure — ARIA was built specifically for you. The technology that large academic medical centers use is now available to independent sites. At a price that makes sense for your business.
Built on HIPAA-compliant infrastructure
All legal agreements signed before any patient data is processed. No exceptions.
Real results from real sites
Client testimonials coming soon — currently onboarding our first sites in South Florida.
Ready to stop leaving randomizations on the table?
One additional randomization per month covers the entire investment. Everything beyond that is pure revenue for your clinic.
Currently accepting clinical trial sites in South Florida · No commitment required for the demo